Showing results (21-30 of 5,666) with videos related to
Sort By:
Pageof 567
Medical Oncology (Northwood, London, England)|December 2, 2022
Efficacy of EGFR-Tyrosine Kinase Inhibitors for advanced non-small cell lung cancer patients harboring rare EGFR mutations of exon 18 E709XYue Hao, Manyi Xu, Huan Zhou, et al.Medical Oncology (Northwood, London, England)|December 5, 2022
Upregulation of SCD1 by ErbB2 via LDHA promotes breast cancer cell migration and invasionJingruo Chen, Sinan Lv, Bohan Huang, et al.Medical Oncology (Northwood, London, England)|June 20, 2022
Targeting cyclin-dependent kinase 1 (CDK1) in cancer: molecular docking and dynamic simulations of potential CDK1 inhibitorsShazia Sofi, Umar Mehraj, Hina Qayoom, et al.Medical Oncology (Northwood, London, England)|June 20, 2022
Identification of oncogenic signaling pathways associated with the dimorphic metabolic dysregulations in gastric cancer subtypesKarthik Balakrishnan, Kumaresan GanesanMedical Oncology (Northwood, London, England)|May 29, 2019
Clinical significance of soluble forms of immune checkpoint molecules in advanced esophageal cancerJuichiro Yoshida, Takeshi Ishikawa, Toshifumi Doi, et al.Medical Oncology (Northwood, London, England)|July 19, 2022
STARD5 as a potential clinical target of hepatocellular carcinomaQi Liu, Xiaoxiao Du, Zhenjun Yu, et al.Medical Oncology (Northwood, London, England)|July 19, 2022
Network pharmacology-based study on apigenin present in the methanolic fraction of leaves extract of Cestrum nocturnum L. to uncover mechanism of action on hepatocellular carcinomaPradeep Kumar, Amit Kumar Singh, Pooja Verma, et al.Medical Oncology (Northwood, London, England)|July 19, 2022
The role of PIP5K1A in cancer development and progressionMan Yin, Yunfei WangMedical Oncology (Northwood, London, England)|July 19, 2022
Fibulin-3 sponges Tiam1 to manipulate MMP-7 activity through β-catenin signaling in oral squamous cell carcinomaHonglei Guo, Yangyang Ji, Bo Zhang, et al.Medical Oncology (Northwood, London, England)|May 25, 2010
MDR-1 polymorphisms (G2677T and C3435T) in B-chronic lymphocytic leukemia: an impact on susceptibility and prognosisG Penna, A Allegra, A Alonci, et al.Pageof 567